Erratum: SOCS3 is an endogenous inhibitor of pathologic angiogenesis (Blood (2012) 120: 14 (2925-2929) DOI: 10.1182/blood-2012-04-422527);SOCS3 is an endogenous inhibitor of pathologic angiogenesis

Blood

Volumn 120, Issue 14, 2012, Pages 2925-2929

  Stahl, Andreas ^a,b   Joyal, Jean Sebastian ^a   Chen, Jing ^a   Sapieha, Przemyslaw ^c   Juan, Aimee M ^a   Hatton, Colman J ^a   Pei, Dorothy T ^a   Hurst, Christian G ^a   Seaward, Molly R ^a   Krah, Nathan M ^a   Dennison, Roberta J ^a   Greene, Emily R ^a   Boscolo, Elisa ^a   Panigrahy, Dipak ^a   Smith, Lois E H ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; MAMMALIAN TARGET OF RAPAMYCIN; SOMATOMEDIN C; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELETION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA NEOVASCULARIZATION; RETINOPATHY; SIGNAL TRANSDUCTION; TUMOR VOLUME;

EID: 84867314763     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2018-10-880906     Document Type: Erratum

References (29)

1. Wang J, Campbell IL. Cytokine signaling in the brain: putting a SOCS in it? J Neurosci Res. 2002;67(4):423-427. (Pubitemid 34117111)
2. Starr R, Willson TA, Viney EM, et al. A family of cytokine-inducible inhibitors of signalling. Nature. 1997;387(6636):917-921. (Pubitemid 27289594)
3. Lebel E, Vallieres L, Rivest S. Selective involvement of interleukin-6 in the transcriptional activation of the suppressor of cytokine signaling-3 in the brain during systemic immune challenges. Endocrinology. 2000;141(10):3749-3763.
4. Jiang Y, Zhang Q, Soderland C, Steinle JJ. TNFalpha and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis. Cell Signal. 2012;24(5):1086-1092.
5. Dey BR, Furlanetto RW, Nissley P. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. Biochem Biophys Res Commun. 2000;278(1):38-43.
6. Marine JC, McKay C, Wang D, et al. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell. 1999;98(5):617-627. (Pubitemid 29418953)
7. Roberts AW, Robb L, Rakar S, et al. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci U S A. 2001;98(16):9324-9329. (Pubitemid 32743915)
8. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med. 2010;16(12):1400-1406.
9. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35(1):101-111. (Pubitemid 24046832)
10. Stahl A, Connor KM, Sapieha P, et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010;51(6):2813-2826.
11. Stahl A, Chen J, Sapieha P, et al. Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol. 2010;177(6):2715-2723.
12. Stahl A, Sapieha P, Connor KM, et al. Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy. Circ Res. 2010;107(4):495-500.
13. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academies Press (US); 2011.
14. Mori H, Hanada R, Hanada T, et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med. 2004;10(7):739-743. (Pubitemid 38937640)
15. Stahl A, Connor KM, Sapieha P, et al. Computer-aided quantification of retinal neovascularization. Angiogenesis. 2009;12(3):297-301.
16. Panigrahy D, Singer S, Shen LQ, et al. PPAR-gamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest. 2002;110(7):923-932.
17. Bielenberg DR, Hida Y, Shimizu A, et al. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest. 2004;114(9):1260-1271. (Pubitemid 40385297)
18. Sapieha P, Stahl A, Chen J, et al. 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of omega-3 polyunsaturated fatty acids. Sci Transl Med. 2011;3(69):69ra12.
19. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double-fluorescent Cre reporter mouse. Genesis. 2007;45(9):593-605. (Pubitemid 350013057)
20. Tugues S, Koch S, Gualandi L, Li X, Claesson-Welsh L. Vascular endothelial growth factors and receptors: antiangiogenic therapy in the treatment of cancer. Mol Aspects Med. 2011;32(2):88-111.
21. Ying M, Li D, Yang L, et al. Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma. J Cancer Res Clin Oncol. 2010;136(10):1617-1626.
22. Smith LE, Shen W, Perruzzi C, et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med. 1999;5(12):1390-1395.
23. Dimberg A. Chemokines in angiogenesis. Curr Top Microbiol Immunol. 2010;341:59-80.
24. Lofqvist C, Willett KL, Aspegren O, et al. Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci. 2009;50(4):1831-1837.
25. Shaw LC, Pan H, Afzal A, et al. Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization. Gene Ther. 2006;13(9):752-760.
26. Sasi SP, Yan X, Enderling H, et al. Breaking the 'harmony' of TNF-alpha signaling for cancer treatment [published online ahead of print December 12, 2011]. Oncogene. doi: 10.1038/onc.2011.567.
27. Kociok N, Radetzky S, Krohne TU, Gavranic C, Joussen AM. Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor- deficient mice. Invest Ophthalmol Vis Sci. 2006;47(11):5057-5065. (Pubitemid 46586413)
28. Kim JH, Kim JE, Liu HY, Cao W, Chen J. Regulation of interleukin-6- induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway. J Biol Chem. 2008;283(2):708-715.
29. Brender C, Nielsen M, Kaltoft K, et al. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma. Blood. 2001;97(4):1056-1062. (Pubitemid 32154293)